Yu C. Fang
State Key Laboratory Of Oncology In South China, P.R. China
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Serum triglyceride and apolipoprotein A1 as dynamic biomarkers in extranodal NK/T-cell lymphoma (ENKTL): A multicenter retrospective and prospective validation study.
Journal: Annals of hematology
Published: July 21, 2025
Antiviral prophylaxis for hepatitis B virus reactivation in T-cell lymphoma patients with resolved hepatitis B virus infection.
Journal: International journal of cancer
Published: May 05, 2025
Diagnostic performance of CT-based node reporting and data system (Node-RADS) for regional lymph node metastasis in periampullary cancer.
Journal: Abdominal radiology (New York)
Published: May 05, 2025
Interactions of Terahertz Photons with Phonons of Two-Dimensional van der Waals MoS2/WSe2/MoS2 Heterostructures and Thermal Responses.
Journal: Materials (Basel, Switzerland)
Published: March 10, 2025
Heat shock factor 1 promotes proliferation and chemoresistance in diffuse large B-cell lymphoma by enhancing the cell cycle and DNA repair.
Journal: Cell death & disease
Published: January 11, 2025
Validation of the Node Reporting and Data System (Node-RADS) for standardized CT evaluation of regional lymph nodes in esophageal squamous cell carcinoma patients.
Journal: European radiology
Published: May 08, 2024
Nimotuzumab combined with docetaxel and cisplatin as first-line treatment for patients with recurrent or metastatic nasopharyngeal carcinoma: a multicenter, phase 2 trial.
Journal: BMC medicine
Published: May 07, 2024
Novel target and treatment agents for natural killer/T-cell lymphoma.
Journal: Journal of hematology & oncology
Published: June 20, 2023
Anlotinib as a third-line or further treatment for recurrent or metastatic nasopharyngeal carcinoma: a single-arm, phase 2 clinical trial.
Journal: BMC medicine
Published: June 01, 2023
Comparison of Chemotherapy Combined With Chidamide Versus Chemotherapy in the Frontline Treatment for Peripheral T-Cell Lymphoma.
Journal: Frontiers in immunology
Published: December 14, 2021
A genomic-augmented multivariate prognostic model for the survival of natural-killer/T-cell lymphoma patients from an international cohort.
Journal: American journal of hematology
Published: December 13, 2021
Last Updated: 09/26/2026